Exelixis
EXEL
EXEL
203 hedge funds and large institutions have $2.78B invested in Exelixis in 2016 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 84 increasing their positions, 43 reducing their positions, and 21 closing their positions.
Holders
203
Holders Change
+37
Holders Change %
+22.29%
% of All Funds
5.42%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
58
Increased
84
Reduced
43
Closed
21
Calls
$64.2M
Puts
$39.6M
Net Calls
+$24.6M
Net Calls Change
+$2.43M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$79.4M |
| 2 |
2
Lord, Abbett & Co
Jersey City,
New Jersey
|
$76.4M |
| 3 |
3
Goldman Sachs
New York
|
$91.6M |
| 4 |
PP
4
PDT Partners
New York
|
$36M |
| 5 |
5
D.E. Shaw & Co
New York
|
$38.3M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ID
226
Integral Derivatives
New York
| – | – | – | – |
|
|
HCM
227
Highbridge Capital Management
New York
| – | – | – | – |
|
|
ST
228
Spot Trading
Chicago,
Illinois
| – | – | – | – |
|
|
SM
229
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|
230
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|